Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.24.1.u1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   24,578,983    
Beginning balance at Dec. 31, 2022 $ 36,887 $ 246 $ 187,008 $ (150,367)
Issuances of common stock:        
Share-based compensation (in shares)   3,782    
Share-based compensation 1,307   1,307  
Payments for taxes related to net share settlement of equity awards (in shares)   (514)    
Payments for taxes related to net share settlement of equity awards (5)   (5)  
Net loss for the period (5,609)     (5,609)
Ending balance (in shares) at Mar. 31, 2023   24,582,251    
Ending balance at Mar. 31, 2023 $ 32,580 $ 246 188,310 (155,976)
Beginning balance (in shares) at Dec. 31, 2023 24,652,729 24,652,729    
Beginning balance at Dec. 31, 2023 $ 21,173 $ 247 193,382 (172,456)
Issuances of common stock:        
Public offering of common stock (in shares)   2,653,848    
Public offering of common stock 16,183 $ 26 16,157  
Share-based compensation (in shares)   126,315    
Share-based compensation $ 1,504 $ 1 1,503  
Option exercises (in shares) 7,500 7,500    
Option exercises $ 21   21  
Payments for taxes related to net share settlement of equity awards (in shares)   (24,047)    
Payments for taxes related to net share settlement of equity awards (151)   (151)  
Net loss for the period $ (4,146)     (4,146)
Ending balance (in shares) at Mar. 31, 2024 27,416,345 27,416,345    
Ending balance at Mar. 31, 2024 $ 34,584 $ 274 $ 210,912 $ (176,602)